• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Assessing Regeneron Pharmaceuticals: Insights From 26 Financial Analysts
July 10, 2025
Tickers REGN
Tags Market News Benzinga BZI/AAR
From Benzinga
2 Beaten-Down Stocks to Buy and Hold
July 05, 2025
Tickers MRNA REGN
Tags REGN MRNA Recent Press Releases
From Motley Fool
Regeneron's Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma
July 03, 2025
Tickers NEWS REGN SNY
Tags Benzinga Market News Stories That Matter
From Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
July 01, 2025
Tickers NEWS REGN
Tags Trading Ideas News Market News
From Benzinga
Regeneron Pharmaceuticals Unusual Options Activity For July 01
July 01, 2025
Tickers REGN
Tags Benzinga Market News BZI/UOA
From Benzinga
Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?
June 25, 2025
Tickers NEWS NKTR REGN SNY
Tags News Trading Ideas Briefs
From Benzinga
$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
June 20, 2025
Tickers NEWS REGN
Tags BZI/POD REGN Market News
From Benzinga
FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder
June 20, 2025
Tickers NEWS REGN SNY
Tags Health Care Benzinga Market News
From Benzinga
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
June 18, 2025
Tickers LLY NEWS NVO REGN
Tags Benzinga Market News LLY
From Benzinga
These Were the 2 Worst-Performing Stocks in the S&P 500 in May 2025
June 15, 2025
Tickers REGN UNH
Tags ^GSPC Market News UNH
From Motley Fool
These Were the 2 Worst-Performing Stocks in the Nasdaq-100 in May 2025
June 13, 2025
Tickers CPRT REGN
Tags REGN Recent Press Releases CPRT
From Motley Fool
Is This Stock a Buy After Acquiring a Potential Zepbound Competitor?
June 12, 2025
Tickers REGN
Tags Market News REGN Recent Press Releases
From Motley Fool
Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies
June 11, 2025
Tickers NEWS NVO REGN
Tags Market News Benzinga Health Care
From Benzinga
Regeneron Pharma Shares Rise Over 3% After Key Signal
June 10, 2025
Tickers REGN
Tags Equities contributors Opinion
From Benzinga
Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season
June 09, 2025
Tickers AZN NEWS REGN SNY
Tags Briefs AZN Top Stories
From Benzinga
MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients
June 05, 2025
Tickers MAIA NEWS REGN
Tags News Top Stories Briefs
From Benzinga
Why Regeneron Is Falling And Why You Should Avoid It
June 04, 2025
Tickers REGN
Tags contributors Equities Opinion
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
June 03, 2025
Tickers NEWS REGN
Tags Market News Benzinga BZI/POD
From Benzinga
Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target
June 02, 2025
Tickers NEWS NVO REGN
Tags REGN Large Cap Market News
From Benzinga
Kymera Therapeutics Says Atopic Dermatitis Potential Matches Sanofi/Regeneron's Blockbuster Dupixent In Early Biomarker Response
June 02, 2025
Tickers KYMR NEWS REGN SNY
Tags Briefs why it's moving KYMR
From Benzinga
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
June 02, 2025
Tickers CRSP REGN
Tags REGN Recent Press Releases Market News
From Motley Fool
Temu Parent PDD, Regeneron Pharmaceutical And Burlington Stores Are Among Top 11 Large-Cap Losers Last Week (May 26-May 30): Are The Others In Your Portfolio?
June 01, 2025
Tickers BAH BURL COO CPRT
Tags PDD Briefs why it's moving
From Benzinga
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
May 31, 2025
Tickers GLD MRVL MULN NPCE
Tags PATH Markets PLTR
From Benzinga
Forecasting The Future: 21 Analyst Projections For Regeneron Pharmaceuticals
May 30, 2025
Tickers REGN
Tags Benzinga Market News REGN
From Benzinga
Wall Street Eyes Modest Losses Despite Upbeat Economic Data
May 30, 2025
Tickers BLRX DELL DJI QQQ
Tags REGN DELL Stocks / Equities
From TalkMarkets
Regeneron Pharmaceuticals Unusual Options Activity For May 30
May 30, 2025
Tickers REGN
Tags Market News Benzinga BZI/UOA
From Benzinga
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
May 30, 2025
Tickers REGN
Tags REGN Benzinga Market News
From Benzinga
Elastic, Gap, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 30, 2025
Tickers AEO COO ESTC GAP
Tags VENU Benzinga Market News
From Benzinga
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data
May 30, 2025
Tickers GSK NEWS REGN SNY
Tags VRNA REGN Large Cap
From Benzinga
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
May 30, 2025
Tickers BLRX BMGL BSLK BURU
Tags Gainers CERO MDCX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap